Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability

Blood

Volumn 92, Issue 4, 1998, Pages 1131-1141

  Tisdale, J F ^a,b   Hanazono, Y ^a   Sellers, S E ^a   Agricola, B A ^a   Metzger, M E ^a   Donahue, R E ^a   Dunbar, C E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; DNA; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; GENE THERAPY; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MACACA; NONHUMAN; PRIORITY JOURNAL; SOUTHERN BLOTTING; STROMA CELL;

EID: 0032529523     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1131.416k41_1131_1141     Document Type: Article

References (48)

1. Dunbar CE, Young NS: Gene marking and gene therapy directed at primary hematopoietic cells. Curr Opin Hematol 3:430, 1996
2. Conneally E, Bardy P, Eaves CJ, Thomas T, Chappel S, Shpall EJ, Humphries RK: Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. Blood 87:456, 1996
3. + cells and corrects the enzyme deficiency in cells from Gaucher patients. Blood 87:1754, 1996
4. Pawliuk R, Kay R, Lansdorp P, Humphries RK: Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer. Blood 84:2868, 1994
5. Pawliuk R, Eaves CJ, Humphries RK: Sustained high-level reconstitution of the hematopoietic system by preselected hematopoeitic cells expressing a transduced cell-surface antigen. Hum Gene Ther 8:1595, 1997
6. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239, 1990
7. Emerson SG: Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: The next generation of cellular therapeutics. Blood 87:3082, 1996
8. Williams DA: Ex-vivo expansion of hematopoietic stem and progenitor cells-Robbing Peter to pay Paul? Blood 81:3169, 1993
9. Szilvassy SJ, Weller KP, Chen B, Juttner CA, Tsukamoto A, Hoffman R: Partially differentiated ex vivo expanded cells accelerate hematologic recovery in myeloablated mice transplanted with highly enriched long-term repopulating stem cells. Blood 88:3642, 1996
10. Muench MO, Firpo MT, Moore MA: Bone marrow tranplant with IL-1 plus kit ligand ex vivo-expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential. Blood 81:3463, 1993
11. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp Hematol 23:461, 1995
12. Varas F, Bernad A, Eueren JA: Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors. Exp Hematol 26:100, 1998
13. Nolta JA, Crooks GM, Overell RW, Williams DE, Kohn DB: Retroviral vector-mediated gene transfer into primitive human hematopoietic progentior cells: Effects of mast cell growth factor (MGF) combined with other cytokines. Exp Hematol 20:1065, 1992
14. Haylock DN, To LB, Dowse TL, Juttner CA, Simmons PJ: Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 80:1405, 1992
15. Koller MR, Emerson SG, Palsson BO: Large-scales expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 82:378, 1993
16. Petzer AL, Zandstra PW, Piret JM, Eaves CJ: Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: Novel responses to Flt3-ligand and thrombopoietin. J Exp Med 183:2551, 1996
17. Zandstra PW, Conneally E, Petzer AL, Piret JM, Eaves CJ: Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci USA 94:4698, 1997
18. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333:283, 1995
19. Holkyoake TL, Alcorn MJ, Richmond L, Farrell E, Pearson C, Green R, Dunlop DJ, Fitzsimons E, Pragnell IB, Franklin IM: CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplant 19:1095, 1997
20. Donahue RE, Kirby MR, Metzger ME, Agricola BA, Sellers SE, Cullis HM: Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or non mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood 87:1644, 1996
21. Cassel A, Cottier-Fox M, Doren S, Dunbar CE: Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp Hematol 21:585, 1993
22. Miller AD: Retroviral vectors. Curr Top Microbiol Immunol 158:1, 1992
23. Dunbar CE, Cottier-Fox M, O'Shaughnessy J, Doren S, Carter CS, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson W, Cowan KH, Young NS, Nienhuis AW: Retroviraily-marked CD34-enriched peripheral blood and bone marrow and cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048, 1995
24. Nienhuis AW, Donahue RE. Karlsson S, Clark SC, Agricola B, Antinoff N, Pierce JE, Turner P, Anderson WF: Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest 80:573, 1987
25. Xu LC, Karlsson S, Byrne ER, Kluepfel-Stahl S, Kassler SW, Agricola BA, Seller S, Kirby M, Dunbar CE, Brady RO, Nienhuis AW, Donahue RE: Long-term in vivo expression of the human glucocerebrosidase gene in non-human primates using retroviral supernatant transduction protocols. Proc NatI Acad Sci USA 92:4372, 1995
26. Dunbar CE, Seidel NE, Doren S, Sellers S, Cline AP, Metzger ME, Agricola BA, Donahue RE, Bodine DM: Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 93:11871, 1996
27. Ziljmans JM, Visser JWM, Laterveer L, Kleiverda K, Heem-Skerk DPM, Kluin PM, Willemze R, Fibbe WE: The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells. Proc Natl Acad Sci USA 95:725, 1998
28. Shah AJ, Smogorzweska EM, Hannum C, Crooks GM: Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro. Blood 87:3563, 1996
29. Rusten LS, Lyman SD, Veiby OP, Jacobsen SEW: The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro. Blood 87:1317, 1996
30. Yonemura Y, Ku H, Lyman SD, Ogawa M: In vitro expansion of hematopoietic progenitors and maintenance of stem cells: Comparison between FLT3/FLK-2 ligand and KIT ligand. Blood 89:1915, 1997
31. Haylock DN, Horsfall MJ, Dowse TL, Ramshaw HS, Niutta S, Protopsaltis S, Peng L, Burrell C, Rappold I, Buhring H-J, Simmons PJ: Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand. Blood 90:2260, 1997
32. Van Beusechem VW, Valerio D: Gene transfer into hematopoietic stem cells of nonhuman primates. Hum Gene Ther 7:1649, 1996
33. Albella B, Segovia JC, Eueren JA: Does the granulocytemacrophage colony-forming unit content in ex vivo-expanded grafts predict the recovery of the recipient leukocytes? Blood 90:464, 1997
34. Pole JG, Gee A, Emerson S, Gallo J, Lee C, Luzins J, Janssen WE, Pick T, White DW, Elfenbein G, Gross S, Weiner R: Myeloablative chemoradiotherapy and autologous bone marrow infusion for treatment of neuroblastoma: Factors influencing engraftment. Blood 78:1607, 1991
35. Haas R, Möhle R, Frühauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M, Hunstein W: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787, 1994
36. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J, Barlogie B: Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood 85:588, 1995
37. Ramshaw HS, Rao SS, Crittenden RB, Peters SO, Weier HU, Quesenberry PJ: Engraftment of bone marrow cells into normal unprepared hosts: Effects of 5-fluorouracil and cell cycle status. Blood 86:924, 1995
38. Orlic D, Girard LJ, Jordan CT, Anderson SM, Cline AP. Bodine DM: The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc Natl Acad Sci USA 93:11097, 1996
39. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, Fagioli F, Berger M, Aglietta M: Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 89:2644, 1997
40. Conneally E, Cashman J, Petzer A, Eaves C: Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci USA 94:9836, 1997
41. Wang JCY, Doedens M, Dick JE: Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo seid-repopulating cell assay. Blood 89:3919, 1997
42. Kurtzberg J, Laughlin M, Graham ML, Smith C, Oison JF, Halperin EC, Ciocci G, Carrier C, Stevens CE, Rubinstein P: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335:157, 1996
43. Cairo MS, Wagner JE: Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation. Blood 90:4665, 1997
44. Moore KA, Ema H, Lemischka IR: In vitro maintenance of highly purified transplantable hematopoietic stem cells. Blood 89:4337, 1997
45. Soma T, Yu JM, Dunbar CE: Maintenance of murine long-term repopulating stem cells in ex vivo culture is affected by modulation of transforming growth factor-β but not macrophage inflammatory protein-lα activities. Blood 87:4561, 1996
46. Borge OJ, Ramsfjell V, Cui L, Jacobsen SEW: Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single cell level: Key role of thrombopoietin. Blood 90:2282, 1997
47. Ramsfjell V, Borge OJ, Cui L, Jacobsen SE: Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: Distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha. J Immunol 158:5169, 1997
48. Bhatia M, Bonnet D, Kapp U, Wang JC, Murdoch B, Dick JE: Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 18:619, 1997